Ivan Hyep

Board Member

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

BCAX

Current role

Board Member

1 call Latest call 2026-03-30

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Bicara Therapeutics Inc. (BCAX)	M.B.A Chief Financial Officer	$438,125	$457,000	—	$2,683,461	—	$20,250	$3,598,836
2023	Bicara Therapeutics Inc. (BCAX)	M.B.A Chief Financial Officer	$350,000	$247,500	—	$1,883,243	—	—	$2,480,743

Earnings-call appearances and filed executive appointments or departures, newest first.